What was the year‑over‑year growth rate for the key therapeutic segments in this quarter?

Answer – Year‑over‑Year Growth for Organon’s Key Therapeutic Segments in Q2 2025

The news release you referenced (Organon’s Q2 2025 earnings announcement on Business Wire) does not include the specific year‑over‑year (YoY) growth percentages for its key therapeutic segments. The brief summary you provided only states that the company “shared results for the second quarter ended June 30 2025” and does not give any quantitative data about segment‑level growth.

What this means

• No growth figures are disclosed in the excerpt you provided.
  
• To obtain the exact YoY growth rates (e.g., for the company’s “core therapeutic segments” such as women’s health, oncology, or specialty medicines), you would need to consult the full earnings release or the accompanying investor presentation/press release that contains the detailed financial tables and segment performance commentary.

How to find the exact numbers

1. Visit Organon’s Investor Relations site (e.g., https://www.organon.com/investor‑relations).
   
2. Look for the “Q2 2025 Earnings Release” (dated August 5 2025). The full press release typically includes a “Segment Performance” or “Key Therapeutic Segments” table that lists YoY growth percentages.
   
3. If the press release is a PDF, search for terms like “growth,” “%,” “year‑over‑year,” “segment,” or the specific therapeutic areas (e.g., “women’s health,” “oncology,” “specialty”).
   
4. Alternatively, check the Form 8‑K filing with the SEC for the same quarter, which often contains the same segment‑level data in the “Management Discussion and Analysis” (MD&A) section.

Typical format of the information

When Organon reports YoY growth for its key therapeutic segments, it usually presents the data in a table similar to the one below (numbers are illustrative, not actual):

The actual percentages will be in the official filing.

Bottom line

The brief news excerpt you supplied does not contain the YoY growth figures for Organon’s key therapeutic segments. To get the exact numbers, you’ll need to refer to the full earnings release or the related SEC filing for the quarter ended June 30 2025. If you locate the full release and share the segment‑performance table, I can help interpret the data for you.